Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.33 |
| ▸ | DGKA | P23743 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1849326 | 0.87 | ALDH1A1 (0.32) | TSHRALDH1A1HSD17B10 | |
| SCHEMBL5720661 | 0.84 | — | — | |
| SCHEMBL18266763 | 0.82 | TSHR (0.33) | TSHRFOLH1DGKACYP1A2DNM1 | |
| SCHEMBL16415782 | 0.79 | DGKA (0.55) | TSHRDGKALMNAKDM4EDUSP3 | |
| SCHEMBL16416009 | 0.79 | DGKA (0.55) | TSHRDGKALMNAKDM4EDUSP3 | |
| SCHEMBL6738496 | 0.78 | EPHX2 (0.39) | TSHRFOLH1MEN1KMT2AHSD17B10 | |
| SCHEMBL1849070 | 0.78 | TSHR (0.46) | TSHRHSD17B10 | |
| SCHEMBL23826 | 0.78 | ALDH1A1 (0.52) | TSHRDGKALMNAALDH1A1 | |
| SCHEMBL10610161 | 0.77 | TSHR (0.41) | TSHRDGKACYP1A2LMNAKDM4E | |
| SCHEMBL10612910 | 0.75 | DGKA (0.36) | TSHRDGKACYP1A2LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8252296-B2 | Aqueous polymer dispersion and use thereof in cosmetics | BASF SE (DE) | 2012-08-28 | — | — | US | disclosed |
| US-8247507-B2 | Cationic polymers as thickeners for aqueous and alcoholic compositions | BASF SE (DE) | 2012-08-21 | — | — | US | disclosed |
| US-8173583-B2 | Use of cationic copolymers of amine-containing acrylates and N-vinylimidazolium salts in hair cosmetic preparations | BASF SE (DE) | 2012-05-08 | — | — | US | disclosed |
| EP-2066705-B1 | CATIONIC POLYMERS AS THICKENERS FOR AQUEOUS AND ALCOHOLIC COMPOSITIONS | BASF SE (DE) | 2011-05-25 | — | — | EP | disclosed |
| EP-2114365-B1 | CATIONIC CONDITIONING AGENT | BASF SE (DE) | 2010-09-01 | — | — | EP | disclosed |
| US-20100204045-A1 | Systemicity Enhancers | BASF SE (DE) | 2010-08-12 | — | — | US | disclosed |
| US-20100179082-A1 | USE OF CATIONIC COPOLYMERS OF AMINE-CONTAINING ACRYLATES AND N-VINYLIMIDAZOLIUM SALTS IN HAIR COSMETIC PREPARATIONS | BASF SE (DE) | 2010-07-15 | — | — | US | disclosed |
| US-20100119468-A1 | CATIONIC CONDITIONING AGENT | BASF SE (DE) | 2010-05-13 | — | — | US | disclosed |
| US-20100040573-A1 | CATIONIC POLYMERS AS THICKENERS FOR AQUEOUS AND ALCOHOLIC COMPOSITIONS | BASF SE (DE) | 2010-02-18 | — | — | US | disclosed |
| US-20080194708-A1 | Cationic Polymers as Thickeners for Aqueous and Alcoholic Compositions | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-14 | — | — | US | disclosed |
| US-20080153925-A1 | Use of Amphiphilic Copolymers as Solubilising Agents | BASF AKTIENGESELLSCHAFT (DE) | 2008-06-26 | — | — | US | disclosed |
| EP-1863858-A1 | CATIONIC POLYMERS AS THICKENERS FOR AQUEOUS AND ALCOHOLIC COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-12 | — | — | EP | disclosed |
| US-20070197767-A1 | Method for producing polymers that are predominantly formed from vinvyl formamide | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-23 | — | — | US | disclosed |
| EP-1781719-A1 | USE OF AMPHIPHILIC COPOLYMERS AS SOLUBILISING AGENTS | BASF Aktiengesellschaft (DE) | 2007-05-09 | — | — | EP | disclosed |
| EP-1646663-B1 | AQUEOUS POLYMER DISPERSION AND USE THEREOF IN COSMETICS | BASF AG (DE) | 2007-01-24 | — | — | EP | disclosed |
| WO-2006097514-A1 | CATIONIC POLYMERS AS THICKENERS FOR AQUEOUS AND ALCOHOLIC COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-21 | — | — | WO | disclosed |
| US-20060153793-A1 | Aqueous polymer dispersion and use thereof in cosmetics | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-13 | — | — | US | disclosed |
| WO-2006018135-A1 | USE OF AMPHIPHILIC COPOLYMERS AS SOLUBILISING AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-23 | — | — | WO | disclosed |
| US-20050265950-A1 | Cross-linked cationic copolymers comprising regulators, and use therof in cosmetic preparations for hair | BASF AKTIENGESELLSCHAFT (DE) | 2005-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194708-A1 | Cationic Polymers as Thickeners for Aqueous and Alcoholic Compositions | ADH1A, ADH1C, PCNA | TSHR 4389/4885FOLH1 2682/4885DGKA 114/4885 |
| US-20060153793-A1 | Aqueous polymer dispersion and use thereof in cosmetics | ALAD, ACMSD, PADI4 | TSHR 4155/4885FOLH1 4006/4885DGKA 1317/4885 |
| US-20100179082-A1 | USE OF CATIONIC COPOLYMERS OF AMINE-CONTAINING ACRYLATES AND N-VINYLIMIDAZOLIUM SALTS IN HAIR COSMETIC PREPARATIONS | ASS1, ACR, PADI1 | TSHR 3874/4885FOLH1 2625/4885DGKA 3949/4885 |
| US-20100040573-A1 | CATIONIC POLYMERS AS THICKENERS FOR AQUEOUS AND ALCOHOLIC COMPOSITIONS | ADH1A, ADH1C, ARCN1 | TSHR 4536/4885FOLH1 2381/4885DGKA 117/4885 |
| US-20080153925-A1 | Use of Amphiphilic Copolymers as Solubilising Agents | VCL, ASS1, CCNL2 | TSHR 4319/4885FOLH1 4541/4885DGKA 1797/4885 |
| US-20100204045-A1 | Systemicity Enhancers | C3AR1, C5, CHRM1 | TSHR 1208/4885FOLH1 2856/4885DGKA 936/4885 |
| US-20100119468-A1 | CATIONIC CONDITIONING AGENT | HLA-DRB1, CD47, CD74 | TSHR 3616/4885FOLH1 2504/4885DGKA 1760/4885 |
| US-20050265950-A1 | Cross-linked cationic copolymers comprising regulators, and use therof in cosmetic preparations for hair | ETF1, MTHFD2, TWF2 | TSHR 2185/4885FOLH1 938/4885DGKA 2722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.